Sign In
Buy PACB
$1.45
-0.180 (-11.04%)
At Close: Jun 05, 2026
Pacific Biosciences Shares Fall As Q4 Earnings Miss Estimates
11:03am, Wednesday, 16'th Feb 2022 Benzinga
Pacific Biosciences of California Inc (NASDAQ: PACB ) reported Q4 sales of $36.02 million , +33% Y/Y, missing the consensus of $36.12 million. The company placed 48 Sequel II or IIe instruments in the quarter, bringing the total installed base to 374, compared to 203 a year … Full story available on Benzinga.com
Pacific Biosciences of California (PACB) Q4 2021 Earnings Call Transcript
05:00am, Wednesday, 16'th Feb 2022 The Motley Fool
PACB earnings call for the period ending December 31, 2021.
Pacific Biosciences of California (PACB) Q4 2021 Earnings Call Transcript
05:00am, Wednesday, 16'th Feb 2022 The Motley Fool
PACB earnings call for the period ending December 31, 2021.
Pacific Biosciences of California, Inc. (PACB) CEO Christian Henry on Q4 2021 Results - Earnings Call Transcript
02:24am, Wednesday, 16'th Feb 2022 Seeking Alpha
Pacific Biosciences of California (PACB) Reports Q4 Loss, Tops Revenue Estimates
10:55pm, Tuesday, 15'th Feb 2022 Zacks Investment Research
Pacific Biosciences (PACB) delivered earnings and revenue surprises of -7.14% and 0.05%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Pacific Biosciences of California, Inc. (PACB) CEO Christian Henry on Q4 2021 Results - Earnings Call Transcript
09:24pm, Tuesday, 15'th Feb 2022
Pacific Biosciences of California, Inc. (PACB) CEO Christian Henry on Q4 2021 Results - Earnings Call Transcript
PacBio Announces Fourth Quarter and Fiscal Year 2021 Financial Results
09:05pm, Tuesday, 15'th Feb 2022 GlobeNewswire Inc.
MENLO PARK, Calif., Feb. 15, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter and fiscal year ended December 31, 2021.
Pacific Biosciences of California (PACB) Reports Q4 Loss, Tops Revenue Estimates
07:15pm, Tuesday, 15'th Feb 2022
Pacific Biosciences (PACB) delivered earnings and revenue surprises of -7.14% and 0.05%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
The Daily Biotech Pulse: Larimar Plunges On Extension Of Clinical Hold, ImmunityBio Gains On Positive Data, Adcom Test Awaits Avenue Therapeutics
01:38pm, Tuesday, 15'th Feb 2022 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
ImmunityBio Says Cancer Combo Therapy Produces Positive Results In Late-Stage Bladder, Thyroid Cancer
Pacific Biosciences of California Q4 2021 Earnings Preview
10:35pm, Monday, 14'th Feb 2022 Seeking Alpha
Pacific Biosciences of California (NASDAQ:PACB) is scheduled to announce Q4 earnings results on Tuesday, Feb. 15, after market close.The consensus EPS estimate is -$0.29
The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More
01:32pm, Sunday, 13'th Feb 2022 Benzinga
Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news flow continued to dominate
Warning: PACB is at high risk of performing badly
09:38am, Thursday, 10'th Feb 2022 Seeking Alpha
Analysts Estimate Pacific Biosciences of California (PACB) to Report a Decline in Earnings: What to Look Out for
08:01pm, Wednesday, 02'nd Feb 2022 Zacks Investment Research
Pacific Biosciences (PACB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Pacific Biosciences of California (PACB) to Report a Decline in Earnings: What to Look Out for
04:08pm, Wednesday, 02'nd Feb 2022
Pacific Biosciences (PACB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PacBio to Report Fourth Quarter and Full Year 2021 Financial Results on February 15, 2022
09:05pm, Tuesday, 01'st Feb 2022 GlobeNewswire Inc.
MENLO PARK, Calif., Feb. 01, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its fourth quarter and full year 2021 financial
